Insider Trading Activity Endo International PLC (NASDAQ:ENDP) – CEO Bought 6,500 shares of Stock

0

Insider Trading Activity For Endo International PLC (NASDAQ:ENDP)

Paul Campanelli , CEO of Endo International PLC (NASDAQ:ENDP) reportedly Bought 6,500 shares of the company’s stock at an average price of 7.71 for a total transaction amount of $50,115.00 SEC Form

Insider Trading History For Endo International PLC (NASDAQ:ENDP)

  • On 11/12/2012 David Holveck, CEO, bought 7,425 with an average share price of $26.84 per share and the total transaction amounting to $199,287.00.View SEC Filing
  • On 4/9/2013 Caroline B Manogue, VP, sold 35,000 with an average share price of $35.00 per share and the total transaction amounting to $1,225,000.00.View SEC Filing
  • On 8/8/2013 Roger Kimmel, Director, bought 5,478 with an average share price of $36.50 per share and the total transaction amounting to $199,947.00.View SEC Filing
  • On 8/26/2013 Caroline Manogue, VP, sold 145,592 with an average share price of $39.40 per share and the total transaction amounting to $5,736,324.80.View SEC Filing
  • On 3/10/2014 Ivan Gergel, EVP, sold 75,637 with an average share price of $72.47 per share and the total transaction amounting to $5,481,413.39.View SEC Filing
  • On 3/10/2014 Arthur Higgins, Director, bought 5,000 with an average share price of $73.00 per share and the total transaction amounting to $365,000.00.View SEC Filing
  • On 4/1/2014 John Delucca, Director, sold 10,384 with an average share price of $68.46 per share and the total transaction amounting to $710,888.64.View SEC Filing
  • Analyst Ratings For Endo International PLC (NASDAQ:ENDP)
    These are 15 Hold Ratings, 5 Buy Ratings .
    The current consensus rating for Endo International PLC (NASDAQ:ENDP) is Hold (Score: 2.25) with a consensus target price of $14.94 , a potential (83.59% upside)

    Analyst Ratings History For Endo International PLC (NASDAQ:ENDP)

    • On 11/13/2015 Standpoint Research Upgraded rating Hold to Buy with a price target of $75.00
    • On 4/2/2016 Nomura Reiterated Rating Buy
    • On 6/6/2016 Goldman Sachs Group, Inc. (The) Initiated Coverage of rating Neutral with a price target of $20.00
    • On 9/29/2016 Northland Securities Upgraded rating Market Perform to Outperform with a price target of $27.00
    • On 1/20/2017 J P Morgan Chase & Co Downgraded rating Overweight to Neutral with a price target of $20.00
    • On 1/27/2017 Piper Jaffray Companies Set Price Target of rating Hold with a price target of $12.00
    • On 1/31/2017 Susquehanna Bancshares Inc Upgraded rating Neutral to Positive

    Recent Trading Activity for Endo International PLC (NASDAQ:ENDP)
    Shares of Endo International PLC closed the previous trading session at 8.14 up +0.52 6.82% with 13,400,643 shares trading hands.